Mitsuo Sawai
Chief Executive Officer at SAWAI GROUP HOLDINGS CO., LTD.
Net worth: 42 M $ as of 31/03/2024
Profile
Mitsuo Sawai is currently the Chairman & Group Chief Executive Officer at SAWAI GROUP HOLDINGS Co., Ltd.
He also holds the position of Chairman at Sawai Pharmaceutical Co., Ltd.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 30/09/2023 | 1,057,000 ( 2.41% ) | 42 M $ | 31/03/2024 |
Mitsuo Sawai active positions
| Companies | Position | Start |
|---|---|---|
| SAWAI GROUP HOLDINGS CO., LTD. | Chief Executive Officer | 01/04/2021 |
Sawai Pharmaceutical Co., Ltd.
 Sawai Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Sawai Pharmaceutical Co., Ltd. engages in the manufacture and sale of prescription pharmaceutical products. Its products include cardiovascular drugs, antihyperlipidemic agents, diabetes, anticancer drugs, and over-the-counter drugs. It operates through the Japan and United States segments. The Japan segment sells manufactured pharmaceuticals to domestic sales companies, wholesale stores and other pharmaceutical manufacturers, as well as directly to medical institutions. The United States segment comprises of holding companies that manages subsidiaries and sell manufactured pharmaceuticals to wholesale stores in the United States. The company was founded by Hanpei Sawai and Noyo Sawai on April 1, 1929 and is headquartered in Osaka, Japan. | Chairman | 23/06/2020 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Sawai Pharmaceutical Co., Ltd.
Sawai Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Sawai Pharmaceutical Co., Ltd. engages in the manufacture and sale of prescription pharmaceutical products. Its products include cardiovascular drugs, antihyperlipidemic agents, diabetes, anticancer drugs, and over-the-counter drugs. It operates through the Japan and United States segments. The Japan segment sells manufactured pharmaceuticals to domestic sales companies, wholesale stores and other pharmaceutical manufacturers, as well as directly to medical institutions. The United States segment comprises of holding companies that manages subsidiaries and sell manufactured pharmaceuticals to wholesale stores in the United States. The company was founded by Hanpei Sawai and Noyo Sawai on April 1, 1929 and is headquartered in Osaka, Japan. | Health Technology |
| SAWAI GROUP HOLDINGS Co., Ltd. |
- Stock Market
- Insiders
- Mitsuo Sawai